Effect of Blue Light Filtration on Visual Performance
Not Applicable
Completed
- Conditions
- Cataract
- Interventions
- Device: Clear clip-on glassesDevice: Blue light filter clip-on glasses
- First Posted Date
- 2013-09-11
- Last Posted Date
- 2015-01-19
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 158
- Registration Number
- NCT01938989
Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®
Phase 4
Completed
- Conditions
- Ocular HypertensionOpen Angle Glaucoma
- Interventions
- First Posted Date
- 2013-09-09
- Last Posted Date
- 2015-05-14
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 307
- Registration Number
- NCT01937299
Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue
Phase 4
Completed
- Conditions
- Ocular HypertensionOpen Angle Glaucoma
- Interventions
- Drug: VehicleDrug: Prostaglandin analogue
- First Posted Date
- 2013-09-09
- Last Posted Date
- 2015-07-28
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 282
- Registration Number
- NCT01937312
Multi-Center Clinical Evaluation of Two Daily Disposable Contact Lenses (Study 2)
Not Applicable
Completed
- Conditions
- Refractive Error
- Interventions
- Device: Nelfilcon A contact lensDevice: UltraFilcon B contact lens
- First Posted Date
- 2013-08-06
- Last Posted Date
- 2013-11-07
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 86
- Registration Number
- NCT01917162
- Locations
- 🇬🇧
Visioncare Research Ltd, Farnham, Surrey, United Kingdom
Safety and Efficacy Evaluation of a New Contact Lens Disinfecting Solution in Soft Contact Lens Wearers
Not Applicable
Completed
- Conditions
- Refractive ErrorMyopiaAstigmatismHyperopia
- Interventions
- Device: renu fresh multi-purpose solutionDevice: FID 120947A contact lens disinfecting solutionDevice: Soft contact lenses
- First Posted Date
- 2013-07-31
- Last Posted Date
- 2015-07-09
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 362
- Registration Number
- NCT01912768
Safety and Efficacy Evaluation of a New Contact Lens Disinfecting Solution in Gas Permeable Contact Lens Wearers
Not Applicable
Completed
- Conditions
- AstigmatismMyopiaRefractive ErrorHyperopia
- Interventions
- Device: FID 120947A contact lens disinfecting solutionDevice: Boston Simplus multi-action solutionDevice: Gas permeable contact lenses
- First Posted Date
- 2013-07-31
- Last Posted Date
- 2015-06-30
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 112
- Registration Number
- NCT01912781
Proof-of-Concept Study of a Single Application of an Investigational Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes
Phase 2
Terminated
- Conditions
- Acute Otitis Media
- Interventions
- Drug: AL-60371/AL-817 otic suspension
- First Posted Date
- 2013-07-26
- Last Posted Date
- 2017-12-06
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 84
- Registration Number
- NCT01908803
Pharmacokinetic Study of AL-60371 Otic Suspension in Pediatric Subjects Following Tympanostomy Tube Surgery
Phase 1
Withdrawn
- Conditions
- Otitis Media
- Interventions
- Drug: AL-60371 otic suspension
- First Posted Date
- 2013-07-26
- Last Posted Date
- 2016-03-08
- Lead Sponsor
- Alcon Research
- Registration Number
- NCT01908764
Multi-Center Clinical Evaluation of Two Daily Disposable Contact Lenses
Not Applicable
Completed
- Conditions
- Refractive ErrorMyopia
- Interventions
- Device: Ultrafilcon B contact lensDevice: Stenfilcon A contact lens
- First Posted Date
- 2013-07-12
- Last Posted Date
- 2015-05-12
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 89
- Registration Number
- NCT01898260
- Locations
- 🇬🇧
Alcon Investigative Site, Surrey, United Kingdom
A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion
Phase 3
Completed
- Conditions
- Symptomatic Vitreomacular Adhesion
- Interventions
- Drug: Sham injection
- First Posted Date
- 2013-06-28
- Last Posted Date
- 2015-11-30
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 251
- Registration Number
- NCT01889251
- Locations
- 🇯🇵
Contact Alcon for Trial Locations, Tokyo, Japan
© Copyright 2025. All Rights Reserved by MedPath